Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study to Image Inflammatory Activity of a Fluorescence Imaging Agent in Excised Human Artery Plaques
Sponsor: Massachusetts General Hospital
Summary
Active inflammation plays a key role in causing Coronary Artery Disease (CAD) and Peripheral Arterial Disease (PAD). Since inflammation is so important in how these diseases start, are diagnosed, and treated, being able to see it clearly in each patient could lead to more personalized and effective care - and may help prevent heart attacks. Right now, there's no imaging technology available to clearly see inflammation inside the coronary arteries. The investigators hope to learn how an imaging drug; called LUMISIGHT (Pegulicianine) can help detect inflammation in blood vessels compared with saline. If the investigators find out that LUMISIGHT is active in humans, the investigators might be able to use it for detecting plaque risk in the future.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
25
Start Date
2026-02-28
Completion Date
2027-12-31
Last Updated
2026-01-14
Healthy Volunteers
No
Interventions
Pegulicianine
Pegulicianine (LUMISIGHT) Inflammatory activity
Placebo
Control group for the study
Locations (1)
Massachusetts General Hospital
Boston, Massachusetts, United States